4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-25-113874
Director bought 1,575 shares at an average $127.28 ($200,466)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2025-09-08 | Purchase | +800 | $127.20 | $101,760 | 47,437 | D |
| Coleman Mark Director | 2025-09-08 | Purchase | +287 | $127.30 | $36,535 | 47,724 | D |
| Coleman Mark Director | 2025-09-08 | Purchase | +488 | $127.40 | $62,171 | 48,212 | D |
| Open-market purchases · 1,575 sh · avg $127.28 · $200,466 | |||||||
Loading xslF345X05/ownership.xml…